Publications & Posters

General MetAP2

Pharmacologic Inhibition of MetAP2 Increases Mitochondrial Number and Activity in Skeletal Muscle Keystone Symposia on Mitochondrial Biology in Heart and Skeletal Muscle, January 2019, Poster 2032
ZGN-201, a MetAP2 Inhibitor, Reduces Body Weight and Normalizes Glucose Tolerance in Overweight Dogs Obesity Society Annual Meeting, October 2010, Poster 763

Zafgen LogoChondrial Therapeutics Logo

Zafgen and Chondrial Therapeutics have merged to form Larimar Therapeutics.

You will be transferred to the new site in a moment.
If you have waited more than a few seconds and you are still seeing this message, please click here.
Thank you.

Chondrial Therapeutics Logo